Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × pembrolizumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

INDUSTRY 149 OTHER 129 NIH 8 FED 3 UNKNOWN 1 NETWORK 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Head & Neck 2 Gastrointestinal 2 Breast 2 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 Dermatologic 1

Conditions

Prostate Cancer Metastatic 1

Interventions

Radiotherapy 29 bicalutamide 21 Gemcitabine 21 Docetaxel 21 Goserelin 18 Carboplatin 18 Paclitaxel 17 Cisplatin 16 Flutamide 15 Doxorubicin 15 Leuprolide 14 Radiotherapy, Conformal 10 Prednisone 10 Gene Expression Profiling 10 Filgrastim 10 Etoposide 9 Vinblastine 8 Radiotherapy, Intensity-Modulated 8 Gonadotropin-Releasing Hormone 8 Buserelin 8 Triptorelin Pamoate 7 Surgical Procedures, Operative 7 Methotrexate 7 Estramustine 7 Androgen Antagonists 7 Radiation 6 Polymerase Chain Reaction 6 Magnetic Resonance Spectroscopy 6 Ifosfamide 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡